Use of a stanol fatty acid ester for reducing serum cholesterol level
AssigneeRaision Tehtaat Oy AB
InventorsTatu Miettinen, Hannu Vanhanen, Ingmar Wester
Life of this patent
Estimating the term…
Abstract
The invention relates to a substance which lowers cholesterol levels in serum and which is a .beta.-sitostanol fatty acid ester or fatty acid ester mixture, and to a method for preparing the same. The substance can be used as such or added to a food.
Claims8
The method of reducing the absorption of cholesterol into the bloodstream comprising orally introducing into the body an effective amount of a substance containing a .beta.-sitostanol fatty acid ester prepared by the interesterification of .beta.-sitostanol with a fatty acid ester containing between 2 and 22 carbon atoms in the presence of an interesterification catalyst.
Dependencies are inferred from the claim text.